Hib-DTP-poliovirus vaccine - Sanofi
Alternative Names: Pent-HiBest; PentacoqLatest Information Update: 04 Apr 2022
At a glance
- Originator sanofi pasteur
- Developer Sanofi
- Class Haemophilus vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 19 Jan 2005 Aventis Pasteur is now called sanofi pasteur
- 21 Feb 1995 Phase-III clinical trials for Diphtheria in United Kingdom (Unknown route)
- 21 Feb 1995 Phase-III clinical trials for Haemophilus infections in United Kingdom (Unknown route)